GLOBE NEWSWIRE | February 14, 2018
Avadel Pharmaceuticals Announces Pricing of $125,000,000 Exchangeable Senior Notes Plus Overallotment Option
Avadel Pharmaceuticals Announces Pricing of $125,000,000 Exchangeable Senior Notes Plus Overallotment Option